UBS Group »

Virax Biolabs Group shares owned by UBS Group

Quarter-by-quarter ownership of Virax Biolabs Group shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Virax Biolabs Group

Tip: Access up to 7 years of quarterly data

All positions including Virax Biolabs Group held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Virax Biolabs Group by UBS Group

Quarter filed Position value Share count Share price at filing
2026-06-30 $12 4 3.00

More positions owned by UBS Group

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Micron Technology (MU)
Eli Lilly & Co. (LLY)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Advanced Micro Devices (AMD)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Ishares Tr Core Msci Eafe (IEFA)

View all positions for UBS Group

Top funds holding Virax Biolabs Group

Jane Street
UBS Group

View all funds holding Virax Biolabs Group